[ET Net News Agency, 6 March 2024] IMMUNEONCO-B (01541) rose 9.7% to HK$16.5.
It hits an intra-day high of HK$16.58, and an intra-day low of HK$13.72, hitting a
historical low. The total shares traded was 86,800, with a value of HK$1.26m. The active
buy/sell ratio is 35:65, with net selling turnover of HK$369,800. CHINA SEC INT'L BRO
accounts for greatest net responsive buying turnover of HK$313,686, with volume weighted
average price of HK$14.067. GUOTAI JUNAN SEC (HK) accounts for greatest net responsive
selling turnover of HK$173,200, with volume weighted average price of HK$15.464.
Basic Information
=================
----------------------------------
Nominal 16.500 % Chg +9.71%
High 16.580 Low 13.720
Shares Tr 86,800 Turnover 1.26m
10-D SMA 20.188 %H.V 119.241
20-D SMA 19.807 VWAP 14.548
50-D SMA 23.764 RSI14 37.473
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 35:65, with net selling
turnover of HK$369,800
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 16.50 +9.71
HUTCHMED (00013) 23.30 +4.25
GENSCRIPT BIO (01548) 15.08 +0.67
INNOVENT BIO (01801) 38.65 -1.28
EVEREST MED-B (01952) 25.30 +8.12
LAEKNA-B (02105) 8.19 +15.68
WUXI BIO (02269) 21.15 +6.07
BEIGENE (06160) 96.60 -1.23
AKESO (09926) 45.25 +1.12
REMEGEN (09995) 23.05 +5.98
---------------------------------------------
(ed)